We commit to bringing more of our medicines to more people, no matter where they are. For all our new medicines, we will systematically integrate access strategies in how we research, develop and deliver globally. And this will be a key measure of success for our leaders and employees. Our commitment is based on three key principles.
As we research and develop new drugs, we will always consider how to get them to more people as quickly as possible, regardless of where they live. We will systematically assess our product portfolio against the unmet needs of underserved populations and integrate these needs, as appropriate, into our drug discovery and development strategy.
Our innovation process will include adapting existing products for many more types of patients in diverse environments.
We will aim to make our products available in countries with the greatest need.
We will continue our work to reduce the burden of malaria and neglected tropical diseases.
Accessibility and affordability
We will work to make our medicines available by considering both effective affordability strategies and innovative solutions to disease management, as well as off-patent solutions to complement our innovative medicines portfolio.
Our prices will strive to take into account the value our products deliver to patients, healthcare systems and society
Our strategies will strive to take into account income levels, local affordability barriers and economic realities, while maintaining the sustainability of our business.
Our patient assistance programs and social business initiatives will be scaled to expand their reach and impact.
Strengthening healthcare systems
A treatment, however, is only as good as the system that delivers it. We will therefore seek opportunities to lower local barriers to healthcare delivery, working in collaboration with governments and other partners to support quality patient care in areas where we can have the greatest impact.
We will help empower patients to take ownership of their health and to better understand and manage their disease.
We will invest in the training and support of healthcare workers to expand their knowledge and improve their ability to help patients.
We will facilitate programs and collaborations that can aid local research and clinical trial capabilities.
We will advocate for and support improvements in policy and healthcare systems design.
These changes will take time and it will not be easy. In order to have a maximum impact on patients’ health, we will need to join forces with others across sectors and industries.
We will continually measure our progress and be transparent in our achievements and failures in the hope that those learnings will inform new models and practices across our industry.
Our leaders will be held accountable and will be compensated based on our progress in meeting this commitment.
Access in Action stories
We’ll be documenting our access journey through the ways we are putting these principles into action.